Follow
Louise Emilsson
Louise Emilsson
Verified email at hsph.harvard.edu
Title
Cited by
Cited by
Year
Review of 103 S wedish H ealthcare Q uality R egistries
L Emilsson, B Lindahl, M Köster, M Lambe, JF Ludvigsson
Journal of internal medicine 277 (1), 94-136, 2015
4252015
Effect of colonoscopy screening on risks of colorectal cancer and related death
M Bretthauer, M Løberg, P Wieszczy, M Kalager, L Emilsson, K Garborg, ...
New England Journal of Medicine 387 (17), 1547-1556, 2022
3092022
Epidemiology and risk factors of colorectal polyps
M Øines, LM Helsingen, M Bretthauer, L Emilsson
Best Practice & Research Clinical Gastroenterology 31 (4), 419-424, 2017
1682017
Examining bias in studies of statin treatment and survival in patients with cancer
L Emilsson, X García-Albéniz, RW Logan, EC Caniglia, M Kalager, ...
JAMA oncology 4 (1), 63-70, 2018
1672018
The COVID-19 pandemic in Norway and Sweden–threats, trust, and impact on daily life: a comparative survey
LM Helsingen, E Refsum, DK Gjøstein, M Løberg, M Bretthauer, ...
BMC public health 20, 1-10, 2020
1412020
Colorectal cancer screening with faecal testing, sigmoidoscopy or colonoscopy: a systematic review and network meta-analysis
HC Jodal, LM Helsingen, JC Anderson, L Lytvyn, PO Vandvik, L Emilsson
BMJ open 9 (10), e032773, 2019
1102019
Risk of colorectal cancer incidence and mortality after polypectomy: a Swedish record-linkage study
M Song, L Emilsson, SR Bozorg, LH Nguyen, AD Joshi, K Staller, J Nayor, ...
The Lancet Gastroenterology & Hepatology 5 (6), 537-547, 2020
1002020
Increased risk of atrial fibrillation in patients with coeliac disease: a nationwide cohort study
L Emilsson, JG Smith, J West, O Melander, JF Ludvigsson
European heart journal 32 (19), 2430-2437, 2011
982011
Rationale and design of the European Polyp Surveillance (EPoS) trials
R Jover, M Bretthauer, E Dekker, Ø Holme, MF Kaminski, M Løberg, ...
Endoscopy, 571-578, 2016
972016
The continuing uncertainty about cancer risk in inflammatory bowel disease
HO Adami, M Bretthauer, L Emilsson, MA Hernán, M Kalager, ...
Gut 65 (6), 889-893, 2016
692016
Perinatal risk factors for development of celiac disease in children, based on the prospective Norwegian Mother and Child Cohort Study
L Emilsson, MC Magnus, K Størdal
Clinical Gastroenterology and Hepatology 13 (5), 921-927, 2015
612015
Guidance for health care leaders during the recovery stage of the COVID-19 pandemic: a consensus statement
JM Geerts, D Kinnair, P Taheri, A Abraham, J Ahn, R Atun, L Barberia, ...
JAMA network open 4 (7), e2120295-e2120295, 2021
602021
The characterisation and risk factors of ischaemic heart disease in patients with coeliac disease
L Emilsson, R Carlsson, M Holmqvist, S James, JF Ludvigsson
Alimentary pharmacology & therapeutics 37 (9), 905-914, 2013
602013
Cardiovascular disease in patients with coeliac disease: a systematic review and meta-analysis
L Emilsson, B Lebwohl, J Sundström, JF Ludvigsson
Digestive and Liver Disease 47 (10), 847-852, 2015
532015
Psychiatric disorders in patients with a diagnosis of celiac disease during childhood from 1973 to 2016
B Lebwohl, L Haggård, L Emilsson, J Söderling, B Roelstraete, ...
Clinical Gastroenterology and Hepatology 19 (10), 2093-2101. e13, 2021
492021
Autoimmune disease in first-degree relatives and spouses of individuals with celiac disease
L Emilsson, C Wijmenga, JA Murray, JF Ludvigsson
Clinical Gastroenterology and Hepatology 13 (7), 1271-1277. e2, 2015
492015
Risk of idiopathic dilated cardiomyopathy in 29 000 patients with celiac disease
L Emilsson, B Andersson, P Elfström, PHR Green, JF Ludvigsson
Journal of the American Heart Association 1 (3), e001594, 2012
492012
Anxiety after coeliac disease diagnosis predicts mucosal healing: a population‐based study
JF Ludvigsson, B Lebwohl, Q Chen, G Bröms, RL Wolf, PHR Green, ...
Alimentary pharmacology & therapeutics 48 (10), 1091-1098, 2018
482018
Risk of small bowel adenocarcinoma, adenomas, and carcinoids in a nationwide cohort of individuals with celiac disease
L Emilsson, C Semrad, B Lebwohl, PHR Green, JF Ludvigsson
Gastroenterology 159 (5), 1686-1694. e2, 2020
452020
Inflammatory bowel disease is more common in patients with IgA nephropathy and predicts progression of ESKD: a Swedish population-based cohort study
J Rehnberg, A Symreng, JF Ludvigsson, L Emilsson
Journal of the American Society of Nephrology 32 (2), 411-423, 2021
442021
The system can't perform the operation now. Try again later.
Articles 1–20